来自Faecalibacterium duncaniae的重组MAM在DNBS诱导的大肠炎中表现出保护作用
Thaís Vilela Rodrigues1,2, Luís Lima de Jesus1,2, Monique Ferrary Américo1,2
1Instituto de Ciências Biológicas, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Microbial cell factories
|December 6, 2025
概括
我们从Faecalibacterium duncaniae A2-165中净化了一种微生物抗炎分子 (MAM),并在体外和结肠炎模型中证明了其直接的抗炎作用. 这验证了MAMM的有效性.
科学领域:
- 肠道微生物群和免疫学
- 益生菌的研究和开发.
- 炎症性肠病 (IBD) 的治疗方法
背景情况:
- 菌 (Faecalibacterium duncaniae A2-165) 是一种与IBD相关的下一代益生菌.
- 微生物抗炎分子 (MAM) 是F. duncaniae A2-165.5的一个关键效应因子.
- 净化MAM的直接抗炎作用以前没有被评估.
研究的目的:
- 为了生产和净化重组MAM (R-MAM).
- 在体外评估R-MAM的直接抗炎活性.
- 在肠道炎症的小鼠模型中评估R-MAM的保护作用.
主要方法:
- 再组合MAM (R-MAM) 在变质条件下生产和净化.
- 在体外测试中使用人类肠道上皮细胞 (HT-29) 和外周血液单核细胞 (PBMC) 进行了测试.
- 使用DNBS诱导的大肠炎小鼠模型来评估体内疗效.
主要成果:
- 纯化的R-MAM在体外诱导了一种抗炎性细胞因子 (cytokine) 概况.
- 在大肠炎模型中,口服R-MAM显著预防了体重减轻.
- R-MAM降低了结肠的重量和厚度,表明炎症减少.
结论:
- 这项研究证实了MAM在肠道炎症方面的治疗潜力.
- 尽管在变质条件下进行净化,但R-MAM显示出直接的抗炎活性.
- 未来的研究应该专注于优化蛋白质稳定性,以提高治疗疗效.
更多相关视频
09:01Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
Published on: March 10, 2015
10.4K
08:34Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation
Published on: July 27, 2022
1.2K
相关概念视频
01:29Bacterial Flora of the Large Intestine
1.7K
The gut microbiome is formed by a vast and diverse community of bacteria that colonizes our large intestine. These bacteria start residing in the gut from birth and continue diversifying throughout life, influenced by factors such as diet, lifestyle, and stress. The gut bacterial community also includes bacteria from food and those that enter the colon through the anus.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
1.7K
01:27Microbiota of the Stomach and Small Intestine
77
The human gastrointestinal (GI) tract is characterized by distinct physicochemical conditions that shape its microbial communities. Among these, the stomach presents a particularly challenging environment for microbial colonization due to its highly acidic pH, ranging from 1 to 3. This extreme acidity effectively limits microbial density. However, certain acid-tolerant microorganisms are capable of surviving in this niche. Notably, Helicobacter pylori can colonize the gastric mucosa,...
77
01:27Microbiota of the Large Intestine
98
The large intestine hosts the most densely populated microbial ecosystem in the human body. This complex community primarily consists of anaerobic bacteria, with Bacillota (formerly Firmicutes) and Bacteroidota (formerly Bacteroidetes) as the predominant groups. The distribution of these microbes varies along different sections of the large intestine, influenced by local environmental factors such as oxygen availability and nutrient composition.The cecum, located at the beginning of the large...
98
01:18Functions of the Gut Microbiota
233
The gut microbiota includes trillions of microorganisms that colonize the human gastrointestinal tract, including bacteria, archaea, viruses, and fungi. This complex ecosystem plays a critical role in maintaining intestinal and systemic health. Most of these microbes inhabit the large intestine, establishing a relatively stable and diverse community that contributes to gut homeostasis through various metabolic, immunological, and protective mechanisms.Dominant bacterial phyla, such as...
233
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
34
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal...
34
01:25Inflammatory Bowel Disease III: Crohn's Disease
35
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
35